Hearts and Minds Investments ups interim dividend
Hearts and Minds Investments (ASX:HM1) announced an increased interim fully franked dividend of 9.5 cents per share, scheduled for payment in April.
Hearts and Minds Investments (ASX:HM1) announced an increased interim fully franked dividend of 9.5 cents per share, scheduled for payment in April.
Bell Financial (ASX:BFG) reported a stellar financial performance for the full year ended Dec. 31, 2025, underscored by a 17.1% increase in net profit after tax to $36 million.
Servcorp (ASX:SRV) reported an underlying net profit before tax of $47 million in H1 FY26, marking a 34% increase compared to the first half of FY25.
Telix Pharmaceuticals (ASX:TLX) submitted a Marketing Authorisation Application in Europe for its glioma imaging candidate, TLX101-Px.
Clinical-stage drug development company Nyrada (ASX:NYR) has released its half-year results for the 2026 fiscal year.
The Northern Territory Government has launched a major international recruitment drive for gas exploration, unveiling a massive new acreage release in the Beetaloo Basin.
Sports Entertainment Group (ASX:SEG) booked an underlying EBITDA of $9.7 million in H1 FY26, representing a 94% organic growth a year earlier.
Catalyst Metals (ASX:CYL) entered into a definitive agreement to purchase a substantial package of Bryah Basin exploration tenements from Albright Metals (ASX:ABR).
SHAPE Australia (ASX:SHA) reported revenue of $553.3 million for H1 FY26, a 16% increase compared to the prior corresponding period.
IDT Australia (ASX:IDT) reported a narrowing of its losses for the half-year ended Dec. 31, 2025.
Lycopodium (ASX:LYL) recorded revenue of $174.5 million and an EBITDA of $29.6 million for H1 FY26, resulting in a net profit after tax of $18.3 million.
Chrysos (ASX:C79) announced a record-breaking financial performance for the first half of FY26, driven by an unprecedented surge in gold sample volumes.